The Manitoba Moonshot is a front-row seat watching one Canadian family trying to save the world from the devastation of type 2 diabetes.

But solving a worldwide pandemic isn’t enough. Unlike Pharma, the goal of the Lautt family is to prevent people from getting sick in the first place. They believe they can detect type 2 decades before any current testing.

If they can detect type 2 diabetes decades earlier, they can prevent people from getting sick in the first place.


They’ll use their scientific methods and financial gains to illustrate that investing in upstream healthcare interventions can be cost-effective for governments and save families from decades of needless suffering.

We spend 90% of our federal budget managing the health costs for the last ten years of a life. What if we shifted even SOME of that budget to the first 70 years into prevention?

SciMar is setting out to prove they are on the brink of a life-changing scientific breakthrough that has the power to save millions of lives.

Join us to witness a small Canadian company pushing boundaries, disrupting the status quo, and challenging the way things have been done for decades.

The time is now. This is a journey you don’t want to miss.

the lautt familY

At the center of SciMar’s work is the cutting-edge research of Dr. W. Wayne Lautt. In 1996, he made a discovery of a hormone called hepatalin that has the power to completely revolutionize the way the world prevents, detects, and treats type 2 diabetes.

Today, Dr. Lautt has teamed up with his son, Mick Lautt, his son-in-law, John West and a dedicated team of researchers to unveil their own moonshot. It has taken a family-sized effort to fuel SciMar’s vision and their mission is just about ready for lift off.


100 years after the discovery of insulin by Dr. Frederick Banting and Charles Best, another group of Canadians have made the next leap forward in the treatment of type 2 diabetes. But the Lautt family does not want history to repeat itself when they bring hepatalin to market.

With insulin, Banting thought he was being altruistic by giving away the patent. 100 years later, we see the Banting's best intentions eroded by the exponential rise of the cost of insulin - especially in the United States - making a life saving medicine unattainable to many who need it most.

When the Lautt family founded SciMar, they decided that the financial gains of this breakthrough would be reinvested in revolutionizing healthcare, advancing science, and protecting the most marginalized.

Share on YoutubeShare on Instagram